Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease

被引：0
|
作者：
Patoulias, Dimitrios [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Gen Hosp Hippokration, Dept Cardiol 2, Thessaloniki, Greece
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 07期
关键词：
D O I：
10.7326/L23-0069
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria
    Patrick, Stephanie A.
    Dabal, Tracey D.
    Jackson, Christopher D.
    Halalau, Alexandra
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (09) : 2915 - 2917
  • [22] Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria
    Stephanie A. Patrick
    Tracey D. Dabal
    Christopher D. Jackson
    Journal of General Internal Medicine, 2021, 36 : 2915 - 2917
  • [23] Safety Profile and Effectiveness of Dapagliflozin in Pediatric Patients with Chronic Kidney Disease
    Van Reeth, Olil
    Caliment, Ancuta
    Garcia, Isabel de la Fuente
    Niel, Olivier
    AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (04) : 463 - 467
  • [24] SHORT-TERM EFFICACY OF DAPAGLIFLOZIN FOR CHRONIC KIDNEY DISEASE PATIENTS
    Nakai, Kentaro
    Hara, Yuichiro
    Inoue, Megumi
    Shukuri, Tomoya
    Hara, Masatoshi
    Nakagawa, Kaneyasu
    Tokumoto, Masanori
    JOURNAL OF HYPERTENSION, 2023, 41 : E420 - E420
  • [25] A SINGLE-CENTER, RETROSPECTIVE STUDY OF BLOOD PRESSURE EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Kawano, Rina
    Hirawa, Nobuhito
    Haruna, Aiko
    Ozawa, Moe
    Haze, Tatsuya
    Suzuki, Shota
    Ohki, Yuki
    Kobayashi, Yusuke
    Fujiwara, Akira
    Saka, Sanae
    Tamura, Kouichi
    JOURNAL OF HYPERTENSION, 2023, 41 : E416 - E416
  • [26] Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease
    McMurray, John J. V.
    Wheeler, David C.
    Stefansson, Bergur V.
    Jongs, Niels
    Postmus, Douwe
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Greene, Tom
    Held, Claes
    Hou, Fan-Fan
    Mann, Johannes F. E.
    Rossing, Peter
    Sjostrom, C. David
    Toto, Roberto D.
    Langkilde, Anna Maria
    Heerspink, Hiddo J. L.
    CIRCULATION, 2021, 143 (05) : 438 - 448
  • [27] How to Demonstrate the Impact of Dapagliflozin on Improving Hyperuricemia in Patients with Chronic Kidney Disease
    Fujioka, Hayato
    Kataoka, Naoya
    Imamura, Teruhiko
    INTERNAL MEDICINE, 2024, 63 (15) : 2227 - 2227
  • [28] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN PANAMA
    Ordonez, J.
    Valdes, R.
    Courville, K.
    Perez, R.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    VALUE IN HEALTH, 2022, 25 (07) : S504 - S505
  • [29] Modeling Metformin and Dapagliflozin Pharmacokinetics in Chronic Kidney Disease
    Shahidehpour, Andrew
    Rashid, Mudassir
    Askari, Mohammad Reza
    Ahmadasas, Mohammad
    Abdel-Latif, Mahmoud
    Fritschi, Cynthia
    Quinn, Lauretta
    Reutrakul, Sirimon
    Bronas, Ulf G.
    Cinar, Ali
    AAPS JOURNAL, 2024, 26 (05):
  • [30] DAPAGLIFLOZIN - NEW SOLUTION IN CHRONIC KIDNEY DISEASE TREATMENT
    Bara, Maciej
    Starownik, Jakub
    Szydlo, Jakub
    Gryszkiewicz, Patryk
    Nieznanski, Jakub
    PROSPECTS IN PHARMACEUTICAL SCIENCES, 2024, 22 (02): : 59 - 64
12345